The XIAP protein combines with the E3 ubiquitin ligase to ubiquitinate a range of targets, including caspases, thereby conferring resistance to chemotherapy or radiotherapy mediated by apoptosis suppression in cancer cells [15]. Here, XIAP is linked to cancer.